Preservica Redefines Digital Preservation with Powerful Built-In AI Tools
4.2.2026 15:00:00 CET | ACCESS Newswire | Press release
OXFORD, UK and BOSTON, MA / ACCESS Newswire / February 4, 2026 / Preservica, the leader in AI-powered Active Digital Preservation™, today announced the rollout of integrated, human-centered AI tools and flexible AI Credits across its product editions. These new features make AI assistance a seamless part of everyday archival workflows, empowering organizations of all sizes to safely adopt AI and scale its use as their needs grow.
"With the sheer volume of digital content in backlogs and being created daily, using AI to assist in archival tasks has now become essential" says Stuart Reed, Chief Product Officer at Preservica "Seamlessly integrating human-centered AI tools across our product editions turns AI for Digital Preservation into reality - enabling organizations of all sizes to accelerate routine work, cut backlogs and enhance discovery."
Developed in collaboration with Preservica's user community and refined through the company's highly rated AI Workshop series, these embedded tools seamlessly extend the platform's existing capabilities and enable archives, records and information management teams across government, academic and business environments to:
Reduce AV and image backlogs quickly
Meet Privacy, Accessibility and FOIA requirements
Improve metadata quality and consistency at scale
Enrich content value and discoverability
Search collections and uncover insights in more intuitive, contextual ways
From days of work to minutes
With Preservica's new human-centered AI capabilities, repetitive archival tasks that once required days or weeks of manual effort can now be completed in just hours, or even minutes, freeing teams to focus on higher value work such as curation, research and advocacy. Advanced capabilities, including AI-driven summarization and semantic search, unlock new possibilities for accessing and using digital archives.
Trusted, human-centered AI
Preservica's AI features are securely integrated into the existing platform and workflows, fully tested, supported and aligned with current AI regulations and standards. Administrators can easily control where and how AI is applied, switching it off or limiting its use to specific collections. Transparent data processing and detailed audit trails eliminate the complexity and risks of piecing together standalone open-source tools. Professional Plus & Enterprise editions also offer secure APIs for organizations that prefer to use their own AI models and tooling.
Integrated AI assistance at a glance.
Below are some of the AI tools Preservica will be rolling out over the coming months. Availability by product edition can be checked on the Pricing page.
Quality check & standardize metadata in minutes
Clean up metadata from multiple sources, auto populate empty fields, resolve inconsistencies and accelerate backlog reduction.
Identify files containing PII for compliance with open data & privacy laws
Quickly and confidently identify files containing Personally Identifiable Information (PII) to support privacy, compliance and responsible record sharing.
Enhance the discoverability of scanned images through OCR
Transform scanned and digitized materials into fully searchable, defensible & compliant assets using built-in Optical Character Recognition (OCR).
Categorize & describe image collections at scale
Automatically detect people, places, and objects to streamline metadata creation for large image collections, enabling rapid categorization of image backlogs.
Automate the transcription and captioning of AV assets
Save hours of time by generating accurate transcripts and captions in minutes to meet accessibility standards and improve navigation with timestamped text.
Semantic search for intent-based discovery
Help users find relevant records faster, surface under described content and respond quickly to audits, FOI requests, eDiscovery needs and compliance inquiries.
Availability for customers
PII detection and OCR tools are available now across supported Preservica editions, as well as AI credits which are consumed based on the usage of AI services. New AI-driven capabilities for automated appraisal and transfer of content from SharePoint and deeper discovery experiences using Microsoft Copilot are in development with more updates coming soon.
Learn more
About Preservica
Preservica is changing the way organizations around the world protect and re-use long-term digital information. Preservica's AI-powered Active Digital Preservation™ archiving software automatically keeps every file alive in future-friendly formats over decades to ensure high-value information can always be quickly found, trusted and actioned for FOI, regulatory compliance, legal, brand and AI needs.
Developed in collaboration with Microsoft, Preserve365®, simplifies compliance and AI adoption by making the archiving, digital preservation and discovery of long-term and permanent records a seamless part of everyday Microsoft 365 and Microsoft SharePoint workflows. This embedded approach empowers Microsoft customers to maximize existing software investments such as Purview, Power Automate and Copilot to automate archiving, reduce cost and risk, simplify discovery and build a foundation of trusted AI-ready long-term content.
Contact information:
Meg Fornataro
York IE
(603) 202-3175
SOURCE: Preservica
View the original press release on ACCESS Newswire
Preservica

Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
AGFA HealthCare Named Best in KLAS(R) 2026 Across Three Enterprise Imaging Segments in the United States4.2.2026 15:45:00 CET | Press release
Industry recognition for the third consecutive year reinforces AGFA HealthCare's clinician-first commitment, and leadership in empowering connected, high-performance imaging environments MORTSEL, BE / ACCESS Newswire / February 4, 2026 / AGFA HealthCare today announced that it has been named Best in KLAS® 2026 across three Enterprise Imaging segments in the United States, with two awards earned for the second consecutive year, underscoring the company's continued leadership in delivering clinician-first imaging solutions trusted by healthcare organizations worldwide. The recognition comes as KLAS Research marks its 30th anniversary, celebrating three decades of amplifying the voice of healthcare providers through independent, data-driven insights. AGFA HealthCare's Best in KLAS distinctions reflect strong customer validation of its Enterprise Imaging platform - designed to empower clinicians to stay in their flow, reduce complexity across imaging workflows, and enable confident clinica
Karbon-X Files Quarterly Report on Form 10-Q Highlighting Strong Revenue Growth and Commercial Scale4.2.2026 15:00:00 CET | Press release
CALGARY, AB / ACCESS Newswire / February 4, 2026 / Karbon-X Corp. (OTCQX:KARX) ("Karbon-X" or the "Company"), a vertically integrated climate solutions company, today announced that it has filed its Quarterly Report on Form 10-Q for the six months ended November 30, 2025. The filing highlights continued momentum in Karbon-X's commercial operations, driven by significant revenue growth and the expansion of its global carbon activities across both compliance and voluntary markets. "Over the past several quarters, we transformed Karbon-X from a developing platform into a scaled, revenue-generating global operator," said Chad Clovis, Chief Executive Officer of Karbon-X Corp. "Revenue increased to $56.5 million (USD), compared to $1.3 million (USD) in the prior-year period, reflecting the strength of our commercial strategy and the growing demand for high-integrity carbon solutions. As we continue to invest in scaling our operations, our expanding global footprint, improved profitability, a
Axon Neuroscience's Immunotherapy Selected for a Landmark Combination-Therapy Alzheimer’s Clinical Trial in US, Supported by a USD 151 Million Grant4.2.2026 14:00:00 CET | Press release
Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a groundbreaking U.S. Alzheimer's disease phase 2 clinical trial (supported by a USD 151 million grant) and, simultaneously, a new platform trial for progressive supranuclear palsy (PSP) (supported by a USD 75 million grant) SAN FRANCISCO, CA / ACCESS Newswire / February 4, 2026 / Axon Neuroscience, a global leader in immunotherapy for human neurodegenerative diseases with an internationally recognized scientific team, announces the achievement of two historic milestones with the potential to significantly influence the future treatment of Alzheimer's disease and progressive supranuclear palsy (PSP): 1. AADvac1 Selected as the First Tau Therapy in the Phase 2 Alzheimer's Tau Platform (ATP) Combination-Therapy Trial An independent panel of leading U.S. scientific and clinical experts selected AADvac1 as the first therapy targeting pathological tau protein to be evaluated in
CHAR Technologies Licenses High-Temperature Pyrolysis Technology to GazoTech SAS for Entry Into European Markets4.2.2026 14:00:00 CET | Press release
TORONTO, ON / ACCESS Newswire / February 4, 2026 / CHAR Technologies Ltd. ("CHAR Tech" or "the Company") (TSXV:YES)(FSE:68K) a leader in sustainable biomass energy solutions, today announced that it has entered into a formal technology know-how licensing agreement with GazoTech SAS ("GazoTech"), a France-based energy developer, to support deployment of CHAR Tech's technology in France and selected European markets. The agreement follows recent commissioning progress at CHAR Tech's Thorold Renewable Energy Facility and complements the Company's ongoing development of larger-scale projects in North America. Under the agreement, CHAR Tech is the licensor of its proprietary High-Temperature Pyrolysis ("HTP") technology, granting GazoTech a know-how licence for projects developed in France as well as certain additional European markets, subject to project-by-project application of the licenced technology. GazoTech has multiple projects in development in France, notably: An industrial integr
Caldwell Strengthens Life Sciences and Healthcare Practice with Addition of Dr. Christoph Themel as Partner3.2.2026 11:30:00 CET | Press release
TORONTO, ON AND LONDON, UK / ACCESS Newswire / February 3, 2026 / Retained executive search firm Caldwell (TSX:CWL)(OTCQX:CWLPF) today announced the addition of Dr. Christoph Themel as a Partner in the firm's Life Sciences and Healthcare Practice. Based in London, Dr. Themel advises boards, investors, and senior leadership teams on executive and non-executive appointments, leadership assessments, and succession planning across the pharmaceutical, biotechnology, and animal health sectors. Dr. Christoph Themel joins Caldwell as partner in the firm's Life Sciences and Healthcare Practice With more than 20 years of experience in executive search and leadership advisory, Dr. Themel is a trusted advisor to big and mid-sized pharmaceutical companies, family-owned enterprises, private equity firms, and portfolio company leadership teams across Europe, the United States, and Asia Pacific. He is particularly known for his ability to partner closely with shareholders and management teams on C-sui
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom